Psychotrophic Drug Therapy of the Tourette's Disorder.
- Author:
Myung Ho LIM
1
;
Soo Churl CHO
Author Information
1. Department of Psychiatry, College of Medicine, Dankook University, Cheonan, Korea. paperose@dku.edu
- Publication Type:Review
- Keywords:
Tourette's disorder;
Psychotrophic drug therapy
- MeSH:
Canada;
Drug Therapy*;
Muscles;
North America;
Prognosis;
Psychotropic Drugs;
Tic Disorders;
Tourette Syndrome*;
Voice
- From:Korean Journal of Psychopharmacology
2013;24(4):147-159
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Tic disorder is a childhood neuropsychological disorder which has the characteristics of abrupt, involuntary, and repetitive stereotyped muscle movement or voice. Tourette's disorder shows a chronic prognosis, and can last for life if no medical treatment is applied. Though the tic disorder has been known for a long time, the underlying cause is still not well known. Psychotropic drugs have long been used for the tic disorder or Tourette's disorder, but few clinical studies were carried out. However, the European Society for the Study of Tourette's syndrome recently reported the clinical guideline of Tourette's syndrome and other tic disorders based on the research findings obtained so far. Also, the guideline for the evidence-based treatment was reported in Canada, and North America. By synthesizing the newly reported foreign guidelines for treatment and review articles, this study aims to investigate the psychotropic drug therapy used for the tic disorder or Tourette's disorder.
